Purkinje cell toxicity is one of the characteristic features of the Go
rdon phenomenon, a syndrome manifested by ataxia, muscular rigidity, p
aralysis, and tremor that may lead to death (Gordon, 1933). Two member
s of the RNase superfamily found in humans, EDN (eosinophil-derived ne
urotoxin) and ECP (eosinophil cationic protein), cause the Gordon phen
omenon when injected intraventricularly into guinea pigs or rabbits. W
e have found that another member of the RNase superfamily, an antitumo
r protein called onconase, isolated from Rana pipiens oocytes and earl
y embryos, will also cause the Gordon phenomenon when injected into th
e cerebrospinal fluid of guinea pigs at a dose similar to that of EDN
(LD(50), 3-4 mu g). Neurologic abnormalities of onconase-treated anima
ls were indistinguishable from those of EDN-treated animals, and histo
logy showed dramatic Purkinje cell loss in the brains of onconase-trea
ted animals. The neurotoxic activity of onconase correlates with ribon
uclease activity. Onconase modified by iodoacetic acid to eliminate 70
% and 98% of the ribonuclease activity of the native enzyme displays a
similar decrease in ability to cause the Gordon phenomenon. In contra
st, the homologous bovine pancreatic RNase A injected intraventricular
ly at a dose 5000 times greater than the LD,, dose of EDN or onconase
is not toxic and does not cause the Gordon phenomenon. A comparison of
the RNase activities of EDN, onconase, and bovine pancreatic RNase A
using three pancreatic RNA substrates demonstrates that onconase is or
ders of magnitude less active enzymatically than EDN and RNase A. Thus
, another member of the RNase superfamily in addition to EDN and ECP c
an cause the Gordon phenomenon. Ribonuclease activity of onconase appe
ars essential for onconase-mediated neurotoxicity. However, substantia
l differences in neurotoxicity observed among some homologous ribonucl
eases cannot be due to their different enzymatic activities; other fea
tures of the enzymes are considered.